Jacobs Levy Equity Management’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $350K | Buy |
39,621
+11,672
| +42% | +$103K | ﹤0.01% | 927 |
|
|
2025
Q1 | $301K | Sell |
27,949
-41,316
| -60% | -$445K | ﹤0.01% | 980 |
|
|
2024
Q4 | $887K | Buy |
+69,265
| New | +$887K | ﹤0.01% | 730 |
|
|
2024
Q3 | – | Sell |
-1,559
| Closed | -$45.2K | – | 1013 |
|
|
2024
Q2 | $45.2K | Buy |
1,559
+130
| +9% | +$3.77K | ﹤0.01% | 942 |
|
|
2024
Q1 | $63.7K | Buy |
+1,429
| New | +$63.7K | ﹤0.01% | 921 |
|
|
2023
Q4 | – | Sell |
-16,268
| Closed | -$478K | – | 1036 |
|
|
2023
Q3 | $478K | Buy |
16,268
+11,289
| +227% | +$332K | ﹤0.01% | 809 |
|
|
2023
Q2 | $317K | Sell |
4,979
-77,611
| -94% | -$4.94M | ﹤0.01% | 871 |
|
|
2023
Q1 | $3.9M | Buy |
+82,590
| New | +$3.9M | 0.02% | 455 |
|